We	O
propose	O
a	O
two	O
-	O
step	O
procedure	O
to	O
personalize	O
drug	O
dosage	O
over	O
time	O
under	O
the	O
framework	O
of	O
a	O
log	B:C3161035
-	I:C3161035
linear	I:C3161035
mixed	I:C3161035
-	I:C3161035
effect	I:C3161035
model	I:C3161035
.	O

We	O
model	B:C0870071
patients	O
'	O
heterogeneity	O
using	O
subject	O
-	O
specific	O
random	O
effects	O
,	O
which	O
are	O
treated	O
as	O
the	O
realizations	O
of	O
an	O
unspecified	O
stochastic	O
process	O
.	O

We	O
show	O
in	O
theory	O
and	O
numerical	B:C2603343
studies	I:C2603343
that	O
the	O
proposed	O
method	O
is	O
more	O
efficient	O
compared	O
with	O
existing	O
approaches	O
,	O
especially	O
when	O
covariates	O
are	O
time	O
varying	O
.	O

In	O
addition	O
,	O
a	O
real	O
data	O
example	O
of	O
a	O
clozapine	B:C0009079
study	B:C2603343
confirms	O
that	O
our	O
two	O
-	O
step	O
procedure	O
leads	O
to	O
more	O
accurate	O
drug	O
dosage	O
recommendations	O
.	O

